CN110938036A - Preparation method of 4-iodine-1H-imidazole - Google Patents

Preparation method of 4-iodine-1H-imidazole Download PDF

Info

Publication number
CN110938036A
CN110938036A CN201911351922.6A CN201911351922A CN110938036A CN 110938036 A CN110938036 A CN 110938036A CN 201911351922 A CN201911351922 A CN 201911351922A CN 110938036 A CN110938036 A CN 110938036A
Authority
CN
China
Prior art keywords
imidazole
iodine
solvent
white solid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911351922.6A
Other languages
Chinese (zh)
Inventor
孙海鹰
方坤森
马宗辉
李联伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201911351922.6A priority Critical patent/CN110938036A/en
Publication of CN110938036A publication Critical patent/CN110938036A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms

Abstract

The invention provides a preparation method of 4-iodine-1H-imidazole, which comprises the following steps: (1) imidazole, iodine and a cosolvent for promoting the solubility of iodine in water react by taking water as a solvent under an alkaline condition, the pH value is adjusted to 7-9 after the reaction is finished, the separated white solid is filtered out, the filtrate is extracted, the solvent is evaporated under reduced pressure and the imidazole is recovered by recrystallization, the recrystallized mother liquor is concentrated, and the obtained white solid is combined with the previously separated white solid to obtain a crude product of the 4-iodine-1H-imidazole; (2) the crude product of 4-iodine-1H-imidazole is recrystallized twice to obtain a pure product of white crystal 4-iodine-1H-imidazole. The invention has simple process, high reaction yield, low production cost and recyclable raw materials.

Description

Preparation method of 4-iodine-1H-imidazole
Technical Field
The invention relates to a new synthesis process of a medical intermediate, in particular to a preparation method of 4-iodo-1H-imidazole.
Background
In the pharmaceutical industry, imidazole groups are important structural components of many biologically active molecules. For example, many compounds with affinity for histamine receptors contain imidazole moieties. By utilizing the 4-iodine-1H-imidazole, imidazole groups can be introduced into different molecules through Suzuki reaction, so that the development of an effective novel synthesis process of the 4-iodine-1H-imidazole has wide practical application and higher economic value. The conventional preparation method of 4-iodo-1H-imidazole includes the following methods: (1) imidazole, iodine monochloride and potassium chloride react to obtain 4-iodine-1H-imidazole. However, iodine monochloride has strong oxidizing property, reacts with water to release heat and generate toxic corrosive gas, has strong stimulation effect on eyes, skin and respiratory tract of human body, is corrosive and even carcinogenic, has low economic benefit, and cannot realize large-scale production in industry. (2) Imidazole, potassium iodide and 1, 3-diiodo-5, 5-dimethylhydantoin are reacted to obtain 4-iodo-1H-imidazole. Since 1, 3-diiodo-5, 5-dimethylhydantoin is expensive, it is expensive to apply it to industrial mass production. (3) Imidazole, iodine and sodium iodide react to generate 4, 5-diiodoimidazole and 2, 4, 5-triiodoimidazole, and then potassium sulfite is used for reducing the 4, 5-diiodoimidazole and the 2, 4, 5-triiodoimidazole to prepare the 4-iodo-1H-imidazole. This method has poor atom economy, requires a large amount of iodine, sodium iodide and potassium sulfite in the reaction process, and potassium sulfite can actually reduce 4-iodo-1H-imidazole, thereby reducing the yield. In addition, a large amount of waste liquid containing potassium sulfite is generated by reduction, and the environmental protection pressure is higher.
The traditional preparation method of 4-iodine-1H-imidazole has the defects of large raw material requirement, high cost and poor reaction atom economy. In order to solve the problems, a novel preparation method of 4-iodo-1H-imidazole is provided.
Disclosure of Invention
The invention aims to provide a preparation method of 4-iodo-1H-imidazole, which has the advantages of simple process, high reaction yield, low production cost and recyclable raw materials.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a preparation method of 4-iodo-1H-imidazole comprises the following steps:
(1) iodination reaction: imidazole, iodine and a cosolvent for promoting the solubility of iodine in water react by taking water as a solvent under an alkaline condition, the pH value is adjusted to 7-9 after the reaction is finished, the separated white solid is filtered out, the filtrate is extracted, the solvent is evaporated under reduced pressure and the imidazole is recovered by recrystallization, the recrystallized mother liquor is concentrated, and the obtained white solid is combined with the previously separated white solid to obtain the crude product of the 4-iodine-1H-imidazole.
(2) And (3) recrystallization: and recrystallizing the obtained 4-iodine-1H-imidazole crude product twice to obtain a 4-iodine-1H-imidazole pure product.
The method is characterized in that the proportion of the fed amount of reactants is optimized, the generation of by-products, namely diiodo-substituted imidazole and triiodo-substituted imidazole, is inhibited by increasing the molar ratio of imidazole, and the pure 4-iodo-1H-imidazole is obtained by a recrystallization method, so that the reduction operation is avoided, and the generation of a large amount of waste liquid containing potassium sulfite is avoided. Under optimized conditions, the generation of 2, 4, 5-triiodoimidazole can be completely inhibited, and the generation amount of 4, 5-diiodoimidazole is greatly reduced. The excess imidazole in the reaction can be recovered by extracting the reaction solution and recrystallizing without significantly increasing the cost.
Preferably, in step (1), the molar ratio of iodine to imidazole is 1: 2-5.
Preferably, in the step (1), the cosolvent for promoting the solubility of iodine in water is one or both of potassium iodide and sodium iodide.
Preferably, in step (1), the molar ratio of iodine to co-solvent is 1: 1-4.
Preferably, in the step (1), the alkaline substance providing alkaline conditions is one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and sodium bicarbonate.
Preferably, in step (1), the molar ratio of iodine to basic substance is 1: 1-5.
Preferably, in the step (1), the solvent for recovering imidazole by recrystallization is one or more of isopropanol, n-butanol, dichloromethane, tetrahydrofuran, ethyl acetate and n-hexane. The ratio of the crude product to the solvent is 1 g: 1-20 mL.
Preferably, in the step (2), the solvent used for recrystallization is one or more of water, methanol, ethanol, isopropanol, ethyl acetate and n-hexane. The ratio of the 4-iodine-1H-imidazole crude product to the solvent is 1 g: 1-20 mL.
The invention has the following beneficial effects:
(1) the invention optimizes the proportion of the material amount, increases the molar ratio of imidazole and reduces the generation ratio of the by-products of diiodo substituted imidazole and triiodo substituted imidazole. The excessive imidazole can be recovered by recrystallization, so that the increase of the raw material cost can be avoided.
(2) The method provided by the invention is used for purifying the 4-iodo-1H-imidazole crude product generated by the iodination reaction by recrystallization, so that reduction by a reducing agent can be avoided, the cost can be reduced, and generation of polluting waste can be avoided.
Detailed Description
The present invention will be described in further detail with reference to examples. It should be noted that these embodiments are preferable examples, and are mainly used for understanding the present invention, but the present invention is not limited to these embodiments. The equipment and materials used in the examples are commercially available or commonly used in the industry, and all methods used are conventional in the art.
Example 1
Sodium hydroxide (24.0 g, 0.60mol) was dissolved in 150mL of water, the temperature was reduced to room temperature, then imidazole (40.8 g, 0.60mol) was added and dissolved with stirring. Sodium iodide (33.8 g, 0.23mol) was dissolved in 45mL of water, the temperature was reduced to room temperature, and iodine (38.1 g, 0.15mol) was added. At 0 ℃, dropwise adding aqueous solution of iodine and sodium iodide into aqueous solution of sodium hydroxide and imidazole, and reacting for 6 hours at 0 ℃ after dropwise adding. After the reaction, the pH was adjusted to 7-8 with concentrated hydrochloric acid, and a solid was precipitated, filtered and dried to obtain 17.1 g of a white solid. The filtrate was saturated with 50 g of sodium chloride, extracted with 300 mL. times.2 of ethyl acetate, the organic layers were combined and concentrated to dryness under reduced pressure to give 19 g of a pale yellow solid, and the 19 g of the pale yellow solid was recrystallized from a mixed solvent containing 20mL of ethyl acetate and 20mL of n-hexane, and dried by suction filtration to give 9.5 g of a white solid, which was the recovered raw material imidazole. Mother liquor is decompressed and concentrated to obtain 9.1 g of white solid, and the white solid is combined with 17.1 g of white solid separated out after the reaction and the neutralization, so that the crude product of the 4-iodine-1H-imidazole is obtained.
And adding the combined 26.2 g of solid into a mixed solvent containing 120mL of water and 4mL of ethanol, heating, refluxing for 1 hour, and filtering while the mixture is hot to obtain a filter cake of 4, 5-diiodo-1H-imidazole. The filtrate was cooled to room temperature and crystallized, and 24.7 g of a white solid was obtained by suction filtration. The white solid was recrystallized from a mixed solvent containing 24mL of isopropyl alcohol and 12mL of n-hexane to obtain 18.4 g of white crystals, i.e., pure 4-iodo-1H-imidazole, with a total yield of 70.2%.
Example 2
Sodium hydroxide (190 g, 4.73mol) was dissolved in 800mL of water, the temperature was reduced to room temperature, and then imidazole (320 g, 4.73mol) was added and dissolved with stirring. Sodium iodide (265 g, 1.77mol) was dissolved in 200mL of water, the temperature was reduced to room temperature, and iodine (300 g, 1.18mol) was added. At 0 ℃, dropwise adding aqueous solution of iodine and sodium iodide into aqueous solution of sodium hydroxide and imidazole, and reacting for 10 hours at 0 ℃ after dropwise adding. After the reaction is finished, the pH value is adjusted to 7-8 by concentrated hydrochloric acid, solid is separated out, and 130 g of white solid is obtained by suction filtration and drying. The filtrate was extracted with ethyl acetate 500mL × 3, the organic layers were combined, concentrated to dryness under reduced pressure to obtain 148 g of a pale yellow solid, which was recrystallized from a mixed solvent containing 100mL of ethyl acetate and 100mL of n-hexane, and dried by suction filtration to obtain 76 g of a white solid, which was the recovered raw material imidazole. The mother liquor is decompressed and concentrated to obtain 70 g of white solid, and the white solid separated out after the reaction and the neutralization is combined to obtain the crude product of the 4-iodine-1H-imidazole.
800mL of water and 25mL of ethanol are added to 201 g of the combined solid, the mixture is heated and refluxed for 1 hour, and the hot mixture is filtered by suction, so that the obtained filter cake is 4, 5-diiodo-1H-imidazole. The filtrate was cooled to room temperature and crystallized, and 190 g of a white solid was obtained by suction filtration. The white solid was recrystallized from a mixed solvent containing 180mL of isopropanol and 120mL of n-hexane to obtain 139 g of white crystals, i.e., pure 4-iodo-1H-imidazole, with a total yield of 69.2%.
The above-described embodiments are only preferred embodiments of the present invention, and are not intended to limit the present invention in any way, and other variations and modifications may be made without departing from the spirit of the invention as set forth in the claims.

Claims (8)

1. A preparation method of 4-iodine-1H-imidazole is characterized by comprising the following steps:
(1) iodination reaction: imidazole, iodine and a cosolvent for promoting the solubility of iodine in water react by taking water as a solvent under an alkaline condition, the pH value is adjusted to 7-9 after the reaction is finished, the separated white solid is filtered out, the filtrate is extracted, the solvent is evaporated under reduced pressure and the imidazole is recovered by recrystallization, the recrystallized mother liquor is concentrated, and the obtained white solid and the previously separated solid are combined to obtain a crude product of the 4-iodine-1H-imidazole.
(2) And (3) recrystallization: and recrystallizing the crude 4-iodo-1H-imidazole product twice to obtain a pure 4-iodo-1H-imidazole product.
2. The process according to claim 1, wherein in step (1), the molar ratio of iodine to imidazole is 1: 2-5.
3. The preparation method according to claim 1, wherein in the step (1), the cosolvent for promoting the solubility of iodine in water is one or both of potassium iodide and sodium iodide.
4. The process according to claim 1, wherein in step (1), the molar ratio of iodine to co-solvent is 1: 1-4.
5. The preparation method according to claim 1, wherein in the step (1), the alkaline substance providing the alkaline condition is one or more of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and sodium bicarbonate.
6. The process according to claim 1, wherein in step (1), the molar ratio of iodine to basic substance is 1: 1-5.
7. The preparation method according to claim 1, wherein in the step (1), the solvent for recovering imidazole by recrystallization is one or more of isopropanol, n-butanol, dichloromethane, tetrahydrofuran, ethyl acetate and n-hexane. The ratio of the crude product to the solvent is 1 g: 1-20 mL.
8. The method according to claim 1, wherein in step (2), the solvent used for recrystallization in step (2) is one or more selected from water, methanol, ethanol, isopropanol, ethyl acetate and n-hexane. The ratio of the 4-iodine-1H-imidazole crude product to the solvent is 1 g: 1-20 mL.
CN201911351922.6A 2019-12-24 2019-12-24 Preparation method of 4-iodine-1H-imidazole Pending CN110938036A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911351922.6A CN110938036A (en) 2019-12-24 2019-12-24 Preparation method of 4-iodine-1H-imidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911351922.6A CN110938036A (en) 2019-12-24 2019-12-24 Preparation method of 4-iodine-1H-imidazole

Publications (1)

Publication Number Publication Date
CN110938036A true CN110938036A (en) 2020-03-31

Family

ID=69912976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911351922.6A Pending CN110938036A (en) 2019-12-24 2019-12-24 Preparation method of 4-iodine-1H-imidazole

Country Status (1)

Country Link
CN (1) CN110938036A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112321512A (en) * 2020-11-25 2021-02-05 上海吉奉生物科技有限公司 Synthesis method of 4, 5-diiodo-1H-imidazole

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1331679A (en) * 1998-12-23 2002-01-16 辉瑞大药厂 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
CN102432543A (en) * 2011-11-07 2012-05-02 沈健芬 Method for synthetizing 4-iodo-1H-imidazole
CN106674121A (en) * 2016-11-22 2017-05-17 杭州励德生物科技有限公司 Preparation method of 4-halogen-1H-imidazole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1331679A (en) * 1998-12-23 2002-01-16 辉瑞大药厂 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
CN102432543A (en) * 2011-11-07 2012-05-02 沈健芬 Method for synthetizing 4-iodo-1H-imidazole
CN106674121A (en) * 2016-11-22 2017-05-17 杭州励德生物科技有限公司 Preparation method of 4-halogen-1H-imidazole

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALEXANDER H. SANDTORV,等: "A Three-Way Switchable Process for Suzuki Cross-Coupling,Hydrodehalogenation, or an Assisted Tandem Hydrodehalogenation and Suzuki Cross-Coupling Sequence", 《ADV. SYNTH. CATAL.》, vol. 355, 31 December 2013 (2013-12-31), pages 3231 - 3243 *
S. L. BONDE,等: "Kinetics of the Rapid Base Catalyzed Iodination of Imidazole and 2-Methylimidazole by Molecular Iodine in Aqueous Medium: pH Effect", 《INTERNATIONAL JOURNAL OF CHEMICAL KINETICS》, 23 April 2013 (2013-04-23), pages 355 - 362 *
SACHIN V. BHILARE,等: "Regioselective Iodination of Arenes Using Iodine/NaBO3 4H2O System in Ionic Liquid", 《SYNTHETIC COMMUNICATIONS》, vol. 38, 31 December 2009 (2009-12-31), pages 2881 - 2888 *
吕金峰,等: "4-碘-1H-咪唑的合成工艺研究", 《科学技术与工程》, vol. 11, no. 15, 30 May 2011 (2011-05-30), pages 3498 - 3499 *
韩平: "咪唑_4(5)_取代基系列化合物的合成研究", 《南京理工大学硕士学位论文》, 31 December 2013 (2013-12-31) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112321512A (en) * 2020-11-25 2021-02-05 上海吉奉生物科技有限公司 Synthesis method of 4, 5-diiodo-1H-imidazole

Similar Documents

Publication Publication Date Title
CN114805314A (en) Synthesis method of Ensaitevir
CN114573560A (en) Preparation method of Voranolan fumarate
CN113698320A (en) Preparation method of L-Carlactonitrile
CN108440409B (en) Green and efficient preparation method of rebamipide
CN110938036A (en) Preparation method of 4-iodine-1H-imidazole
JP3440129B2 (en) Method for producing glutamine derivative
JPS6030666B2 (en) Method for producing optically active mercaptocarboxylic acid
KR20150084165A (en) Method for preparing of nafamostat mesilate
CN112939893B (en) Synthesis method of 4- (4-aminophenyl) -3-morpholinone
CN113461508B (en) Preparation method of alpha-ketophenylalanine calcium
CN113861056A (en) Synthetic method of hydrophilic micromolecule amino acid
CN117247339B (en) Preparation method of alkylamine derivative
CN109535025B (en) Preparation method of Evonib intermediate 3, 3-difluorocyclobutylamine hydrochloride
CN111233857B (en) Synthetic method for continuously producing pexidininib
CN114213283B (en) Method for preparing [2- [1- (Fmoc-amino) ethoxy ] acetic acid by one-pot method
JP3572668B2 (en) Method for producing acylaminophthalic acid derivative
US2481597A (en) Substituted propionic acids and processes of preparing the same
JP2009221185A (en) Method for producing toluidine compound
CN117088939A (en) Preparation method of pidotimod
CN114409558A (en) Sacubitril intermediate impurity and synthetic method thereof
KR100310936B1 (en) A process for preparing N-(4-methylbenzenesulfonyl)-N'-(3-azabicyclo[3,3,0]octane)urea
CN117756729A (en) Preparation method of deuterium-celecoxib and intermediate thereof
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
KR850001529B1 (en) Process for the preparation of amino acid phenol-ester derivation
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200331

WD01 Invention patent application deemed withdrawn after publication